EMA Authorised: Abseamed (epoetin alfa) — Medice Arzneimittel Pütter GmbH Co. KG

View source ↗

Summary

EMA has authorised Abseamed, an epoetin alfa product by Medice, for treatment of anemia associated with chronic kidney disease and certain hematologic condition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease
• Myelodysplastic Syndromes

Drugs mentioned

• Abseamed (epoetin alfa)

Snippet

Status: Authorised. Therapeutic area: Anemia;Kidney Failure, Chronic;Blood Transfusion, Autologous;Myelodysplastic Syndromes. MAH: Medice Arzneimittel Pütter GmbH Co. KG. Decision date: 11/07/2025